We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cloned Nerve Cells Cure Parkinson's-Like Disease in Mice

By Biotechdaily staff writers
Posted on 08 Oct 2003
Researchers have found a novel way of producing therapeutic nerve cells that can cure mice with Parkinson's-like disease. More...
Their work was described in the September 21,2003, online issue of Nature Biotechnology.

An earlier study showed that unlimited numbers of genetically matched dopamine nerve cells would be generated by using cloned stem cells whose genetic material originated from the mouse's own tail. Dopamine neurons are the ones that are lost in patients with Parkinson's disease. However, this method worked for cells derived from some mice but not from others.

The researchers developed a better way of selectively generating dopamine neurons that eliminates variability in order for therapeutic cloning to work consistently for every animal. Using this new technique, the team differentiated stem cells into genetically matched neural cells in vitro. They were able to develop nerve cells specific to the forebrain, midbrain, hindbrain, and spinal cord, as well as supporting glial cells. The next step is to develop unique cell lines for a number of Parkinsonian mice and show that these cloned cells can cure each individual mouse.

"The new technique is a model system that will provide scientists with the opportunity to see how the brain develops in vitro, and conduct experiments such as observing in a culture dish the developmental consequences of disrupting single or multiple genes,” said senior author Lorenz Studer, M.D., head of the stem cell and tumor biology laboratory at Memorial Sloan-Kettering Cancer Center (MSKCC, New York, NY, USA; www.mskcc.org), who worked with a team of colleagues from MSKCC, Cornell University (New York, NY, USA), and the University of Connecticut (Storrs, USA).




Related Links:
Memorial Sloan-Kettering

Gold Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Silver Member
PCR Plates
Diamond Shell PCR Plates
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: POC fingerstick blood testing enables faster hepatitis B DNA testing outside centralized laboratories (Photo courtesy of Conor Ashleigh)

POC Testing for Hepatitis B DNA as Effective as Traditional Laboratory Testing

Hepatitis B is a viral infection that attacks the liver and can lead to cirrhosis, liver failure, and liver cancer over time. Despite being preventable through vaccination and treatable in its chronic... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Industry experts gather at WHX Labs Dubai to discuss how leadership must adapt as AI and automation transform the laboratory (Photo courtesy of Shutterstock)

WHX Labs in Dubai spotlights leadership skills shaping next-generation laboratories

WHX Labs in Dubai (formerly Medlab Middle East), held at Dubai World Trade Centre (DWTC) from 10–13 February, brings together international experts to discuss the factors redefining laboratory leadership,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.